A visible-residue observation illustrates the gap between a clean-status label and demonstrated cleaning effectiveness.
What happened?
FDA described residue in a manufacturing tank verified as clean, together with missing cleaning-validation studies for shared equipment. The letter requested a retrospective assessment and remediation.
EDITORIAL INTERPRETATION
Why does it matter?
The equipment-status decision needs a defensible connection to evidence. The letter concerns the cited facility and is not a universal new requirement.
Key points
- Investigate the clean-status decision.
- Assess other equipment within the potential scope.
- Connect remediation to ongoing verification.
Practical impact
Discussion prompt: trace how a failed visual check reaches the quality unit, changes equipment status and initiates an impact assessment.
Related regulatory requirements
CV-REQ-000003
Define dirty and clean hold times ↗
CV-REQ-000004
Support worst-case product selection ↗
CV-REQ-000005
Use visual inspection within validation ↗
CV-REQ-000007
Include microbial and endotoxin risk ↗
CV-REQ-000008
Define cleaning responsibilities ↗
CV-REQ-000009
Prepare a study protocol ↗
CV-REQ-000013
Document the validation conclusion ↗
CV-REQ-000014
Reflect actual equipment use ↗
CV-REQ-000015
Describe the cleaning study ↗
CV-REQ-000018
Monitor cleaning after validation ↗
CV-REQ-000019
Review the validated state ↗
CV-REQ-000020
Establish and reassess HBELs ↗
CV-REQ-000023
Justify the changeover control strategy ↗
CV-REQ-000024
Manage the cleaning lifecycle ↗
CV-REQ-000025
Address manual cleaning variability ↗
CV-REQ-000026
Assess new products before introduction ↗
CV-REQ-000029
Use HBELs within risk assessment ↗
CV-REQ-000030
